Monday, December 28, 2015 9:25:03 AM
On December 27, 2015, Tom Fernandez and Marek Biestek resigned as members of the board of directors (the “Board”) of KaloBios Pharmaceuticals, Inc. (the “Company”). There were no disagreements with the Company that led to the resignations.
Item 5.03. Amendments to Articles of Incorporation or By-Laws; Change in Fiscal Year.
On December 27, 2015, the Board approved an amendment to the Company’s Amended and Restated Bylaws to provide a procedure for the Board to fix a record date for the determination of stockholders entitled to participate in certain corporate actions, including, among others, to express consent to corporate action in writing without a meeting.
The foregoing description of the amendment to the Amended and Restated Bylaws does not purport to be a complete statement of the provisions thereof. Such description is qualified in its entirety by reference to the amendment, a copy of which is included as Exhibit 3.2 to this Form 8-K and is incorporated herein by reference thereto.
Click For Link
Blessings to All
TRUTH
I've never claimed to have all the answers but feel i'm beginning to corner the market in questions worthy of them.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM